Fund: FTBDF
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912 | |
LU0109394709 | |
03-04-2000 | |
Equity | |
Equity Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
USD | |
1,000 | |
5.75% |
Date | NAV |
---|---|
25-04-2024 | 38.5700 |
24-04-2024 | 39.1200 |
23-04-2024 | 39.3500 |
22-04-2024 | 38.8500 |
19-04-2024 | 38.5000 |
18-04-2024 | 38.6800 |
17-04-2024 | 39.3000 |
16-04-2024 | 39.5500 |
15-04-2024 | 39.6200 |
12-04-2024 | 40.5500 |
11-04-2024 | 41.7300 |
10-04-2024 | 41.1100 |
09-04-2024 | 41.6200 |
08-04-2024 | 41.2800 |
05-04-2024 | 41.2200 |
04-04-2024 | 40.9000 |
03-04-2024 | 41.5000 |
02-04-2024 | 41.4800 |
01-04-2024 | 42.4000 |
31-03-2024 | 42.6800 |
29-03-2024 | 42.6800 |
28-03-2024 | 42.6800 |
27-03-2024 | 42.6800 |
26-03-2024 | 42.1200 |
25-03-2024 | 42.1800 |
22-03-2024 | 42.6400 |
21-03-2024 | 43.0200 |
20-03-2024 | 42.6800 |
19-03-2024 | 42.1900 |
18-03-2024 | 41.7400 |
15-03-2024 | 42.2800 |
14-03-2024 | 42.1500 |
13-03-2024 | 43.1700 |
12-03-2024 | 42.8200 |
11-03-2024 | 42.7500 |
08-03-2024 | 43.3000 |
07-03-2024 | 43.6600 |
06-03-2024 | 43.8700 |
05-03-2024 | 43.8800 |
04-03-2024 | 44.1200 |
01-03-2024 | 44.6900 |
29-02-2024 | 43.5100 |
27-02-2024 | 44.4500 |
26-02-2024 | 43.8200 |
23-02-2024 | 43.3600 |
22-02-2024 | 42.2000 |
21-02-2024 | 42.2000 |
20-02-2024 | 42.3600 |
18-02-2024 | 42.7700 |
16-02-2024 | 42.7700 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 6247 |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -8.56% | -2.40% | 23.82% | 14.55% | 13.47% | -3.43% | 5.12% | 3.49% | 5.47% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.15% | -3.12% | 1.29% | 3.49% | 2.91% | ||||||
Volatilita od priemernej výkonnosti | 9.29% | 29.30% | 8.99% | 6.57% | 5.24% |
Long | Short | Net | |
---|---|---|---|
Stock | 98.50% | 98.50% | |
Bond | |||
Other | 0.61% | 0.61% | |
Cash | 1.24% | 0.35% | 0.89% |
Aktíva | 14,251 mil. |
Počet akcíí | 93 |
Počet dlhopisov | 0 |
Priebež. popl. | 1.81 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.04 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 3.01% |
Large | 23.19% |
Medium | 12.89% |
Small | 20.68% |
Micro | 32.30% |
P/E | 16.58% |
P/BV | 4.29% |
Basic Materials | 1.22% |
Healthcare | 96.38% |
Corporate | 0.61 |
Derivatives | 0.89 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 66.84 |
AA | 0.00 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 33.16 |
United States | 85.18% |
Canada | 0.98% |
Latin America | |
United Kingdom | 3.89% |
Eurozone | 3.88% |
Europe - ex Euro | 4.22% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 98.14% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 6.85% | Regeneron Pharmaceuticals Inc | Healthcare | 6.43% |
Vertex Pharmaceuticals Inc | Healthcare | 5.34% | Ascendis Pharma A/S ADR | Healthcare | 4.22% |
Gilead Sciences Inc | Healthcare | 3.07% | AstraZeneca PLC ADR | Healthcare | 3.01% |
Biogen Inc | Healthcare | 2.88% | Applied Therapeutics Inc | Healthcare | 2.71% |
Jazz Pharmaceuticals PLC | Healthcare | 2.67% | Intra-Cellular Therapies Inc | Healthcare | 2.62% |